Chronic Hepatitis C
Chronic Hepatitis C Treatments
Treatment of chronic hepatitis C depends on the person. Even though you have chronic hepatitis C, you may not need or get help from treatment. Some people may not be able to handle treatment because of side effects.
The FDA has approved the following treatments for hepatitis C:
- Incivek (telaprevir)
- Olysio (simeprevir)
- Pegylated interferon alfa-2a
- Pegylated interferon alfa-2b
- Sovaldi (sofosbuvir)
- Harvoni (sofosbuvir, ledipasvir)
- Standard interferon alfa
- Victrelis (boceprevir)
- Viekira Pak (ombitasvir, paritaprevir, dasabuvir, ritonavir)
Hepatitis C treatments are changing quickly. Until recently, the most common treatment was a blend of shots and pills that usually came with some unpleasant side effects. It typically combined a shot of interferon or pegylated interferon with the pills ribavirin and another drug. But recently, two new drugs have been approved as hepatitis C treatments.
The newer drugs Olysio (simeprevir) and Sovaldi (sofosbuvir) cure more people in less time with fewer side effects. The drugs are taken together with interferon and ribavirin. Doctors hope that soon more people will be able to stop taking interferon, the treatment that causes so many side effects.
Chronic Hepatitis C Outlook
In the best case, the hepatitis C virus won't be found in the blood 6 months after treatment ends. Although the virus isn't gone, it stops growing. After treatment, make sure you have healthy habits and see your doctor regularly.
The outlook for chronic hepatitis C is usually good. In some cases, people may develop cirrhosis and liver disease. They may need a liver transplant.